Navigation Links
Quark Pharmaceuticals Announces Data Indicating Potential Utility of QPI-1007 for Treatment of Glaucoma
Date:7/27/2009

FREMONT, Calif., July 27 /PRNewswire/ -- Quark Pharmaceuticals, Inc., a development-stage pharmaceutical company discovering and developing novel RNA interference (RNAi)-based therapeutics, today announced data suggesting that QPI-1007 prevents progressive retinal ganglion cell (RGC) loss in an increased ocular pressure (IOP) rat model of glaucoma. The experiments performed by Prof. Adriana Di Polo of the Department of Pathology and Cell Biology, Universite de Montreal, indicate that QPI-1007 has the potential to treat patients with glaucoma. QPI-1007 is being evaluated in advanced IND-enabling preclinical studies as a neuroprotective agent for eye diseases.

QPI-1007 is Quark's first proprietary siRNA drug candidate developed in collaboration with BioSpring GmbH, with its own intellectual property that gives Quark freedom to operate in the siRNA IP space. Previously announced studies have demonstrated a robust neuroprotective effect of QPI-1007 in two additional models of retinal ganglion cell (RGC) death - induced by optic nerve crush or axotomy. In those studies, QPI-1007 was administered immediately after the optic nerve injury. In the current IOP study, QPI-1007 was administered 2 weeks after disease induction when more than 25% of RGCs have already been lost. Whereas RGC loss progressed in the control eyes, loss of RGCs was completely blocked in the QPI-1007-treated eyes

Dr. Daniel Zurr, Quark's Chief Executive Officer, stated, "Quark is pleased to announce additional data supporting the therapeutic potential of QPI-1007 -- the first siRNA drug candidate based on our own IP -- as well as our proven ability to advance siRNA products from discovery to the clinic. Our leadership position within the RNAi field is set to continue with the upcoming IND filing for QPI-1007 to support initial clinical studies in non-arteritic anterior ischemic optic neuropathy. Quark has the largest portfolio of clinical-stage s
'/>"/>

SOURCE Quark Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. Quark Pharmaceuticals Receives FDA Approval of IND for Kidney Transplant siRNA Drug DGFi
2. Quark Pharmaceuticals to Present at the 20th Annual Piper Jaffray Health Care Conference
3. Quark Pharmaceuticals Presents Data on Synthetic siRNAs for Prevention of Ocular and Inner Ear Sensory Cell Damage
4. Quark Pharmaceuticals Announces the Presentation of Data Indicating Potential Utility of QPI-1002 in Chronic Kidney Disease at the RNA Interference Summit
5. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
8. Idenix Pharmaceuticals to Present at Two Upcoming Investor Conferences
9. Vista Partners Updates Coverage on Tapestry Pharmaceuticals
10. Transcept Pharmaceuticals, Inc. to Present at UBS 2007 Global Life Sciences Conference
11. Crystal Research Associates, LLC Issues Executive Informational Overview(R) (EIO(R)) on Tapestry Pharmaceuticals, Inc.

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)...re-USNewswire/ -- ,, Expert Panel to Discuss ..., A special press briefing will be held Wednesday,...ng a panel of top experts who will discuss the rec...elease of revised screening mammography guidelines...experts and government authorities dispute the gui...
(Date:12/2/2009)...cal Products Inc., an industry leader in healthcar...ces the opening of its new headquarters in the Irv...Research Drive, Irvine, California 92618. In addit...he Irvine Spectrum plus an assembly and distributi...t expansion reflects Links Medical,s rapid growth ...
(Date:12/2/2009)...firm prevails in counterclaim against three plaint...of business dispute over work done on hotel constr...Fla. (Lexis Nexis) December 2, 2009 -- The Tampa-b... completed the settlement of a two-year legal disp...,s client, ConArt, Inc., , ,ConArt, a Georgia-base...
(Date:12/2/2009)...Dec. 1 Last month on a prominent n..., Associate Professor at the Stanford Sleep Disord...ne, recommended the Ecotones Duet Sleep Sound Mach...ing to achieve a better night,s sleep with minimal...m for people when they are sleeping," said Dr. Pel...
(Date:12/2/2009)...ire-USNewswire/ -- Targeted breast ultrasound of s... a safe, reliable and cost-effective alternative t...ing to the findings of two studies presented today... of North America (RSNA). ,, "By performing hig...ber of expensive and avoidable invasive diagnostic...
Breaking Medicine News(10 mins):Health News:Wednesday, Dec. 2: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 2Health News:Wednesday, Dec. 2: News From the 95th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago 3Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 2Health News:Links Medical Opens New Headquarters, Prepares to Launch Medical-Grade Manuka Honey 3Health News:Gallagher Keenan Obtains $500,000 Settlement for ConArt, Inc. in Dispute with Florida Hotel Companies 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 2Health News:Sleep Specialist Dr. Rafael Pelayo Recommends ASTI's Ecotones Duet Sleep Sound Machine 3Health News:Targeted Breast Ultrasound Can Reduce Biopsies for Women Under Forty 2
...l authorities in Jaipur will check the mushrooming...growing complaints of skin problems from customers...overnment for approval after detailed discussions,...sion to enact the act was taken to check the rapid...
... not even the bird flu scare deters the Bhopal res... the reduction in the chicken prices, the people, ...re enjoying a royal feast of chicken. 'No do...rchant Hilal Jafri. Ali, who resides in the Budhwa...
... the only laboratory equipped to handle the avian ...oss the country. Tiny vials of chicken blood and p...s. // These samples are sent by the farmers from p... Security Animal Disease Laboratory in Bhopal, is ...
...nd Campbell in Portland Square are quitting the NH...o sign up the new national health contracts by Apr... opted out. Previously dentists had to give their ...mbria Primary Care Trusts (PCTs) cannot yet say ho...
...udy in the March 17 issue of the Journal of Clinic... Alzheimer’s disease is also useful in improving c...in tumor patients after they undergo radiation the...pezil (trade name: Aricept), showed a marked impro...
...an Research Centre in Sex, Health and Society whic... that the HIV infection rates have jumped 28%.// ...HIV-AIDS Victoria said that it was a real wake-up ... years old. Brent Allan, who runs counseling ...
Other Medicine News:Health News:Alzheimer’s Disease Drug Could Improve Quality Of Life After Radiatio 2Health News:HIV Infection Rates on the Rise in Victoria 2
(Date:12/1/2009)... , NEW YORK, Dec. 1 Re...h report is available in its catalogue: ,, Mol... http://www.reportlinker.com/p0164231/Molecular-Di...cular diagnostics market is being driven by severa...ed and easy-to-handle techniques, which combine op...
(Date:12/1/2009)... , NEW YORK, Dec. 1 Re...h report is available in its catalogue: ,, Con... of Market Trends & Opportunities ,, http...-Outsourcing-CRO---A-Global-Update-of-Market-Trend...sourcing (CRO), which came into being in the seven...
(Date:12/1/2009)... , NEWNAN, Ga., Dec. 1 ...ty surface treatments for medical devices and of s...en, MD, FACR, FACC, FSCAI, founder and medical dir...in Miami, Florida, will discuss the CATANIA(TM) St...nnovations in Cardiovascular Interventions Confere...
Breaking Medicine Technology:Reportlinker Adds Molecular Diagnostics - A World Market Review 2Reportlinker Adds Molecular Diagnostics - A World Market Review 3Reportlinker Adds Molecular Diagnostics - A World Market Review 4Reportlinker Adds Molecular Diagnostics - A World Market Review 5Reportlinker Adds Molecular Diagnostics - A World Market Review 6Reportlinker Adds Molecular Diagnostics - A World Market Review 7Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 2Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 3Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 4Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 5Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 6Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 7Reportlinker Adds Contract Research Outsourcing (CRO) - A Global Update of Market Trends & Opportunities 8Dr. Barry Katzen to Present CATANIA(TM) Coronary Stent Data in Tel Aviv 2Elderplan Opts for Care to Cares Radiology Network 57373 1Elderplan Opts for Care to Cares Radiology Network 57373 2IH Systems RIVA Top Pick for Directors of Pharmacy 57370 1IH Systems RIVA Top Pick for Directors of Pharmacy 57370 2Jumpstart Medicine Opens Two New Locations in San Francisco 57367 1Jumpstart Medicine Opens Two New Locations in San Francisco 57367 2Jumpstart Medicine Opens Two New Locations in San Francisco 57367 3
...nesday,s Satellite Symposium,3: The Challenges of ...e,International Society of Heart and Lung Transpla...ns, clinicians and researchers discussed some of,t...ransplant outcomes in,patients with CF., A highli...holderia,Cenocepacia is an Absolute Contradiction ...
...ed at the Upcoming ECCMID Conference, REINACH, Sw...published on 9 April, Arpida Ltd. (SWX: ARPN) toda...inical programme with,intravenous iclaprim in comp.... Extensive data on ASSIST-1 has been presented at...ST-2 will be presented at the upcoming 18th,Europe...
Other Medicine Technology:Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting 2Lung Transplants in Cystic Fibrosis Patients With Life-Threatening Bacteria Sparks Debate at ISHLT Meeting 3Arpida Provides Further Comments on the Pivotal Phase III Trials 2Arpida Provides Further Comments on the Pivotal Phase III Trials 3Arpida Provides Further Comments on the Pivotal Phase III Trials 4
MaxMara Eyewear
Emporio Armani Eyewear
SphygmoCor Px Pulse Wave Analysis System test
Ted Baker London Eyewear Collection
Medicine Products: